About the Journal

EXCLI Journal (eISSN 1611-2156) is a platinum open access journal, that means

1. all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.

2. There are no fees for authors or their institutions who submit their articles.

Articles published in EXCLI Journal are licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License

You are free to:

  • Share — copy and redistribute the material in any medium or format
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially

under the following term:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Aims and Scope

EXCLI Journal publishes original research reports, authoritative reviews and case reports of experimental and clinical sciences.

The journal is particularly keen to keep a broad view of science and technology, and therefore welcomes papers which bridge disciplines and may not suit the narrow specialism of other journals. Although the general emphasis is on biological sciences, studies from the following fields are explicitly encouraged (alphabetical order):

aging research, cell biology, clinical and preclinical research, drug development, environmental health, ergonomics, gastroenterology and hepatology, genetics, epigenetics and genomics, immunology, neuroscience and behavioral sciences, oncology and cancer research, pharmacology and toxicology, physiology, biochemistry and metabolomics, psychology, regenerative medicine and stem cell research, systems biology

Only original scientific submissions are considered. All articles are reviewed by independent experts (peer review) or editors (editorial review) to ensure the quality of the submitted work.

EXCLI Journal is a platinum open access journal listed in DOAJ, Web of Science, EBSCO, Pubmed, and PubmedCentral. All articles will be deposited at the Deutsche Nationalbibliothek (Frankfurt/Main) as well as in PubmedCentral and in Pubmed.

Open access to full text articles of this journal is managed by IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund, with no commercial interest. EXCLI Journal provides free access (Open Access) to its contents according to the basic assumption that the free public availability of research benefits a worldwide knowledge exchange. The articles are distributed under the terms of the Creative Commons Attribution License (CC BY 4.0).

Publication is free of costs for scientists. There will be no article processing charges, neither for the authors nor for their institutions.

Color pictures and other media are also published free of costs.

Journal's History

EXCLI Journal was founded in 2002 in Germany, at Mainz University by M.A. von Mach and J.G. Hengstler. The journal was transferred from Mainz to Dortmund to IfADo (Leibniz Research Centre for Working Environment and Human Factors) in the middle of 2007, when Prof. Hengstler as editor-in-chief of EXCLI Journal became head of the Toxicology Department of IfADo in Dortmund.